OnDosis is an innovative supplier to the pharmaceutical industry, focusing on the development of precision and flexible dosing solutions for oral solid medicines. Established as an AstraZeneca spin-out in 2017 and headquartered in Sweden, OnDosis is pioneering a first-in-category technical platform designed to administer medications formulated as multi-particulates, including granules, pellets, powders, and mini tablets. The company provides a connected handheld device that patients or caregivers can use in a home setting to deliver individualized dosing and manage dose adjustments effectively. This integration of intelligent dosing and digital capabilities marks a significant advancement in prescription regimens.

Services include:
- Drug Delivery Devices & Systems
- Machinery & Equipment

OnDosis is committed to revolutionising the pharmaceutical landscape through its state-of-the-art dosing technology and user-centric solutions. For more information, please visit ondosis.com.